» Articles » PMID: 28742762

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors

Abstract

The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical professionals who evaluate living kidney donor candidates and provide care before, during and after donation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach and guideline recommendations are based on systematic reviews of relevant studies that included critical appraisal of the quality of the evidence and the strength of recommendations. However, many recommendations, for which there was no evidence or no systematic search for evidence was undertaken by the Evidence Review Team, were issued as ungraded expert opinion recommendations. The guideline work group concluded that a comprehensive approach to risk assessment should replace decisions based on assessments of single risk factors in isolation. Original data analyses were undertaken to produce a "proof-in-concept" risk-prediction model for kidney failure to support a framework for quantitative risk assessment in the donor candidate evaluation and defensible shared decision making. This framework is grounded in the simultaneous consideration of each candidate's profile of demographic and health characteristics. The processes and framework for the donor candidate evaluation are presented, along with recommendations for optimal care before, during, and after donation. Limitations of the evidence are discussed, especially regarding the lack of definitive prospective studies and clinical outcome trials. Suggestions for future research, including the need for continued refinement of long-term risk prediction and novel approaches to estimating donation-attributable risks, are also provided.In citing this document, the following format should be used: Kidney Disease: Improving Global Outcomes (KDIGO) Living Kidney Donor Work Group. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(Suppl 8S):S1-S109.

Citing Articles

Improving healthcare services for living kidney donors: an experience-based approach in the Netherlands.

Sipma W, van Londen M, Visser A, de Jong M, Ahaus K Front Public Health. 2025; 13:1512852.

PMID: 40071116 PMC: 11893550. DOI: 10.3389/fpubh.2025.1512852.


Relationship between new-onset proteinuria and the volume of the non-donated kidney before and after donation in living kidney donors.

Ogata M, Miyauchi T, Osako K, Imai N, Sakurai Y, Shinoda K Clin Exp Nephrol. 2025; .

PMID: 39934590 DOI: 10.1007/s10157-025-02633-8.


Isolated microhematuria in potential kidney donors: evaluating kidney biopsy findings with dipstick urinalysis and urine microscopy results.

Hammad E, Obeid D, Broering D, Shah Y, Brockmann J, Marquez K Clin Kidney J. 2025; 18(1):sfae371.

PMID: 39830308 PMC: 11739450. DOI: 10.1093/ckj/sfae371.


The utility of split function testing in determining recovery of glomerular filtration rate after living kidney donation: a cohort study.

Crowe K, McManus S, Glen J, Stevenson K, McLaughlin I, Nicol A BMC Nephrol. 2025; 26(1):31.

PMID: 39827110 PMC: 11742774. DOI: 10.1186/s12882-025-03956-0.


Do Factors Influencing Acceptance of Kidney Stone Formers as Donors Predict Subsequent Stone Events?.

Keddis M, Howard M, Zhang N, Quillen J, DCosta M, Khamash H Clin Transplant. 2024; 39(1):e70069.

PMID: 39737621 PMC: 11687201. DOI: 10.1111/ctr.70069.


References
1.
Rook M, Bosma R, van Son W, Hofker H, van der Heide J, Ter Wee P . Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant. 2008; 8(10):2077-85. DOI: 10.1111/j.1600-6143.2008.02355.x. View

2.
Oh C, Jeon K, Kim H, Kim S, Kim Y, Pelletier S . Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation. Kidney Int. 2005; 67(2):744-9. DOI: 10.1111/j.1523-1755.2005.67136.x. View

3.
Spinner M, Saab G, Casabar E, Bowman L, Storch G, Brennan D . Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation. 2010; 90(4):412-8. PMC: 2924927. DOI: 10.1097/TP.0b013e3181e81afc. View

4.
Kofman T, Audard V, Narjoz C, Gribouval O, Matignon M, Leibler C . APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. Am J Kidney Dis. 2014; 63(5):816-9. DOI: 10.1053/j.ajkd.2013.12.014. View

5.
Theodoropoulos N, Jaramillo A, Penugonda S, Wasik C, Brooks K, Ladner D . Improving syphilis screening in deceased organ donors. Transplantation. 2014; 99(2):438-43. DOI: 10.1097/TP.0000000000000323. View